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ABSTRACT 
 
The present study focused on determining the 
prevalence of biofilm-forming ability in Enterococ-
cus faecalis, E. faecium, and unusual Enterococcus 
clinical isolates, and comparison of resistance and 
the prevalence of selected virulence factors among 
biofilm-positive strains. The ability to form biofilm 
was detected in 13.3% of E. faecalis, 90% of                 
E. faecium, and 57.1% of unusual Enterococcus 
strains (p=0.026). All E. faecalis strains were 
susceptible to β-lactams, while 37.5% of unusual 
and all E. faecium isolates were resistant to these 
antibiotics. Resistance to gentamicin was detected in 
75% of E. faecalis, 55.5% of E. faecium, and 25% 
of other strains; resistance to streptomycin in 25%, 
83.3%, and 50%, respectively. Analysis of the 
virulence revealed that the enterococcal surface 
protein (esp) gene was found in all E. faecium, 
75.0% of E. faecalis, and 37.5% of other strains; 
collagen adhesin gene (ace) in 100%, 25.0%, and 
37.5%; and hyaluronidase gene (hyl) in 83.3%, 0%, 
and 37.5%, respectively. Analysis of the resistance 
and virulence patterns showed that E. faecium 
isolates had the greatest variety of virulence and 
resistance determinants, while the lowest variety 
was exhibited by unusual strains. These findings 
indicate that unusual biofilm-producing Entero-
coccus strains have lower resistance and virulence 
potency than E. faecalis and E. faecium. 
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1. INTRODUCTION 
 Today, Enterococcus spp. are the fourth most 
common etiological factor in nosocomial infections 
in Europe [1]. Although these cocci are members of 
the microbiota of the human gastrointestinal tract, 
they often infect the bloodstream, surgical sites, and 
urinary tract, due to their multiresistance to many 
antimicrobials [2, 3]. Enterococcus spp. have an 
intrinsic resistance to cephalosporins, lincosamides, 
and low levels of aminoglycosides, and they can 
easily acquire resistance, most prominently to 
glycopeptides and aminoglycosides (high-level 
resistance), by means of mutations or as a result of 
transfer and incorporation of genes located on 
mobile genetic elements, such as plasmids and 
transposons [1, 4]. Moreover, these bacteria have 
the ability to form strong biofilm structures, and to 
produce several virulence factors, such as entero-
coccal surface protein (Esp), aggregation substance 
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(As), collagen adhesion (Ace), hyaluronidase (Hyl), 
and gelatinase (GelE) [5-7]. Esp is the factor that 
mediates the colonization, and, together with GelE, 
has been suggested to be involved in biofilm 
formation [5-7]. Ace and EfaA are principal viru-
lence traits associated with infective endocarditis, 
whereas Hyl causes tissues damages [5-7]. The 
majority of nosocomial enterococcal infections are 
caused by E. faecalis and E. faecium. However, 
today there is an increasing prevalence of infections 
caused by other rarely isolated species, for example: 
E. avium, E. gallinarum, E. durans, and E. casseli-
flavus [8-10]. 
 Biofilm is an assemblage of microbial cells 
enclosed in a self-produced polysaccharide matrix 
and attached to a biotic or abiotic surfaces, provi-
ding an optimal microenvironment for growth,             
and facilitates transmission of mobile determinants 
between microorganisms [11, 12]. Evidence sug-
gests that bacteria in biofilms are more resistant to 
antimicrobials and hosts factors than other 
microorganisms and are extremely difficult to 
eradicate [13]. Likewise, among Enterococcus, it is 
suggested that an ability to produce biofilm is a very 
important virulence factor which has a major impact 
on the course of nosocomial infections [5, 7]. 
Unfortunately, our knowledge about the mecha-
nisms and determinants involved in the process              
of biofilm formation among enterococci is still 
insufficient [14]. The ability to create biofilm has 
been suggested to occur less frequently among              
E. faecium strains compared to E. faecalis strains, 
but, astonishingly, data about biofilm-forming 
ability among unusual enterococcal species are very 
limited and unclear [14, 15]. Furthermore, there are 
only a few reports about the differences in resistance 
and virulence of various biofilm-producing Entero-
coccus species [13, 16, 17]. This prompted us to 
determine the prevalence of biofilm-forming ability 
among E. faecalis, E. faecium, and unusual Entero-
coccus spp. clinical isolates. Then, we focused on 
the comparison of the antibiotic resistance, the 
ability to hemolyze, and the presence of selected 
virulence genes among these three groups of 
biofilm-producing Enterococcus spp. strains. More-
over, the next goals of this study were to determine 
their exact resistance profiles, and to indicate the 
antibiotic with the highest activity against these 
strains. 
2. MATERIAL AND METHODS 
 
2.1. Strains 
 
 Tests were performed on sixty-four entero-
coccal isolates: thirty E. faecalis, twenty E. faecium, 
and fourteen others (five E. avium, three E. casse-
liflavus, three E. gallinarum, three E. durans), 
isolated from clinical specimens from patients 
hospitalized at the University Hospital in Bialystok 
(Poland) from December 2013 to January 2015. 
Isolates were recovered from various clinical 
materials, mostly blood, peritoneal fluid, broncho-
alveolar lavage (BAL), feces, urine, and pus. Most 
of the collected isolates were gathered from the 
intensive care unit and a hematology clinic.  
2.2. Identification and susceptibility testing 
 
 The identification and susceptibility testing 
were conducted on the automated VITEK 2 system 
(bioMérieux, France) according to the manufactu-
rer’s instruction using VITEK 2 GP and AST-P516 
cards, respectively. Susceptibility to ampicillin, 
imipenem, gentamicin, streptomycin, vancomycin, 
teicoplanin, linezolid, and tigecycline was inter-
preted according to the European Committee on 
Antimicrobial Susceptibility Testing (EUCAST) 
recommendations (breakpoint tables for interpreta-
tion of minimum inhibitory concentrations, MIC, 
and zone diameters; version 5.0, 2015; 
http://www.eucast.org).  
 
2.3. Biofilm and hemolysin production 
 
 The tube method [18, 19] and Congo red agar 
(CRA) method [20, 21] were used to assess the 
ability of tested isolates to biofilm formation. Each 
experiment was repeated three times for each strain. 
Strains that demonstrated the ability to produce 
biofilm by both methods were considered as biofilm 
positive (BIO+) isolates. Hemolysin production was 
determined on Columbia blood agar supplemented 
with 5% sheep blood (OXOID, United Kingdom) 
[22].  
 
2.4. DNA extraction 
 
 In the next step, genomic DNA was extracted 
293 | Sieńko et al.   Comparison of biofilm-producing Enterococcus spp. 
European Journal of Biological Research 2017; 7 (4): 291-298 
 
from overnight E. faecium cultures using a Genomic 
Mini Kit (A&A Biotechnology, Poland) according 
to the manufacturer’s guidelines.  
 
2.5. PCR detection of virulence genes 
 
 Then, PCR assays were performed to detect 
the following virulence genes: gelE, ace, hyl, esp, 
as, and cyl. The primers sequences are listed in 
Table 1. PCR amplification was performed in 25 µl 
mixtures using 2 µl of DNA solution, 1 µl of each 
primer, 8.5 µl of nuclease-free water, and 12.5 µl           
of PCR master mix (DNA Gdańsk, Poland). 
Samples were subjected to an initial denaturation           
at 94ᴼC for 5 min, followed by 30 cycles of 
denaturation at 94ᴼC for 1 min, annealing at an 
appropriate temperature for 1 min, and elongation   
at 72ᴼC for 1 min using a DNA thermocycler 
(SensoQuest GmbH, Germany).  
PCR products were separated electrophore-
tically on the Sub-Cell GT apparatus (Bio-Rad, 
USA) at 5 V/cm for 100 min on a 1.5% agarose gel 
(Sigma-Aldrich, USA) containing 0.5% ethidium 
bromide (MP Biomedicals, USA) in Tris-borate-
EDTA (ethylenediaminetetraacetic acid) buffer. 
Then, amplicons were visualized and photographed 
using the ChemiDoc XRS imaging system and 
Quantity One 1-D analysis software (Bio-Rad). The 
positions of obtained products were estimated with 
the molecular weight marker PerfectTM 100-1000 bp 
DNA ladder (EURx, Poland). To confirm the 
presence of the above-mentioned virulence genes, 
DNA sequencing was carried out on selected PCR 
products by the GENOMED S.A. company in 
Poland. The sequences were aligned and compared 
with reference sequences achieved using GenBank 
with the Basic Local Alignment Search Tool 
(BLAST) algorithm.  
 
 
Table 1. PCR primers, annealing temperatures, and product sizes for detection of virulence genes.  
Virulence 
gene Primers 
Product size 
(bp) 
Annealing 
temperature (C̊) Reference 
gelE 5’ AAT TGC TTT ACA CGG AAC GG 3’ 5’ GAG CCA TGG TTT CTG GTT GT 3’ 548 52 [23] 
ace 
5’ GGC CAG AAA CGT AAC CGA TA 3’ 
5’ CGC TGG GGA AAT CTT GTA AA 3’ 353 
hyl 5’ ACA GAA GAG CTG CAG GAA ATG 3’ 5’ GAC TGA CGT CCA AGT TTC CAA 3’ 276 
55 [24] 
esp 
5’ AGA TTT CAT CTT TGA TTC TTG G 3’ 
5’ AAT TGA TTC TTT AGC ATC TGG 3’ 510 
as 
5’ CACGCTATTACGAACTATGA 3’ 
5’ TAAGAAAGAACATCACCACGA 3’ 375 
cyl 5’ TGG ATG ATA GTG ATA GGA AGT 3’ 5’ TCT TTC ATC ATC TGA TAG TA 3’ 517 
 
 
2.6. Statistical analysis 
 
 STATA 13.1 (StataCorp LP, USA) was         
used for statistical analysis. Differences among             
E. faecalis, E. faecium, and unusual enterococcal 
strains were assessed by the Chi-square test and 
Fisher’s exact test. Results with p<0.05 were 
considered significant.  
 
3. RESULTS AND DISCUSSION 
  
 The present study focused on determining the 
prevalence of biofilm-forming ability among three 
enterococcal groups: E. faecalis, E. faecium, and 
other clinical isolates, and on comparison of the 
antibiotic resistance and the prevalence of selected 
virulence traits between BIO+ strains from these 
groups. Interestingly, we found that the ability to 
form biofilm occurred in 4/30 (13.3%) E. faecalis, 
18/20 (90%) E. faecium, and 8/14 (57.1%) rarely 
isolated strains: 5 E. avium, 1 E. durans, 1 E. casse-
liflavus, and 1 E. gallinarum (statistically significant 
difference, p=0.026). Studies by other authors 
showed different results; in Greece, the ability to 
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produce biofilm was found in 60.9% of E. faecalis 
isolates [25], in Italy - in 80% of E. faecalis strains 
[26]. In the case of E. faecium isolates, in India, 
Italy, Turkey, and Spain, this ability occurred         
much less frequently (0%, 28.8%, 48%, and 75%, 
respectively) [5, 8, 27, 28]. Lleo et al. [17] described 
the biofilm-forming ability among four out of 
twelve unusual enterococcal strains (33.3%), which 
our study supports. However, in contrast to our 
findings, Dworniczek et al. [29] indicated the lack 
of these features in rare species. These varied results 
indicate that the level of the ability to produce 
biofilm among different Enterococcus species varies 
with geographic location.  
 In the next step of our research, only BIO+ 
strains (30/64) were chosen for further investigation. 
A comparison of antibiotic resistance among                 
E. faecalis, E. faecium and other isolates showed 
that all E. faecalis strains were susceptible to tested 
ß-lactams, while 37.5% of other strains and all            
E. faecium isolates were resistant to these antibio-
tics. These results strongly overlap with results 
recently published by us [30] and other researchers 
[9, 16, 31]. Resistance to gentamicin was detected  
in 75% of E. faecalis, 55.5% of E. faecium, and 
25% of other strains; resistance to streptomycin in 
25%, 83.3%, and 50%, respectively. Findings from 
our previous work showed that more E. faecium 
isolates were resistant to aminoglycosides: 76%             
to gentamicin, and 91.4% to streptomycin [30]. 
Interestingly, a study by Tan et al. [9] demonstrated 
that all unusual enterococcal isolates from blood 
were susceptible to gentamicin and around 80%            
of them were susceptible to ß-lactams. Therefore, 
the authors concluded that combination therapy 
(penicillin with aminoglycosides) could be easily 
used for the treatment of serious infections caused 
by rare species of Enterococcus, such as bacteremia 
and sepsis. This finding is not confirmed in our 
survey. We revealed that resistance to glycopeptides 
occurred only in the case of four (22.2%) E. faecium 
isolates; two strains from the rare group,                          
E. gallinarum and E. casseliflavus, showed intrinsic 
resistance to vancomycin. Similar results were 
obtained by other authors [9, 32]. We concluded that 
tigecycline and linezolid had the highest activity 
against all studied isolates (100% susceptibility), 
including those resistant to glycopeptides and 
aminoglycosides. Many studies confirmed that these 
antibiotics are a valuable therapeutic option in 
serious enterococcal infections [33-35]. Unfortu-
nately, resistance to these drugs has been recently 
reported [34, 36, 37], indicating that resistance to 
newer antibiotics is also increasing, and develop-
ment of new targeted enterococcal drugs is needed. 
 Our comparative analysis of the prevalence of 
virulence genes among E. faecalis, E. faecium, and 
other strains revealed that the esp gene was found in 
all E. faecium, 75% of E. faecalis, and 37.5% of 
other strains. Similar proportions were seen by other 
researchers [6, 11, 25, 38, 39, 40]. These findings 
indicate that this gene has a connection with 
biofilm-forming ability, especially in E. faecium 
strains. However, many authors found that there           
is no association between the presence of the esp 
gene and biofilm production [5, 14, 29, 41]. These 
conflicting results suggest that esp requires inte-
ractions with other virulence traits to result in 
biofilm enhancement.  
 Considering the presence of other virulence 
factors in our studied BIO+ groups, we found             
that the ace gene occurred in all E. faecium, 25% of 
E. faecalis, and 37.5% of unusual isolates; hyl in 
83.3%, 0%, and 37.5%, respectively. The gelE gene 
was detected only in E. faecalis strains. According 
to the literature, the presence of gelE and as genes 
among E. faecalis is very common, whereas they are 
extremely rarely present in E. faecium and rare 
enterococcal isolates; consequently, they are not 
necessary in the process of biofilm formation among 
these species [5, 25, 28, 42, 43]. These assumptions 
are confirmed by our survey. However, some 
researchers imply that there is a strong relationship 
between gelE and the ability to form biofilm [12, 
15]. Other virulence genes, cyl and as, were also 
found only in E. faecalis isolates, which is in 
accordance with other studies [22, 40, 44]. 
  The exact resistance and virulence patterns 
among all tested BIO+ strains are shown in Table 2. 
No predominant profile among each group was 
identified, not only due to small sample size, but 
also because of high interindividual variability of 
examined traits among tested Enterococcus spp. 
groups. However, we have found that E. faecium 
isolates showed the greatest variety of virulence and 
resistance determinants, while the lowest variety 
was exhibited by the unusual strains group. 
Moreover, all E. faecium strains carried resistance to 
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three or more antibiotics and had the ability to 
hemolyse. Different results were seen in recent 
research by Tsikrikonis et al. [25], who detected 
only 1.9% of hemolysin-producing E. faecium 
clinical isolates. We also found that one E. faecalis 
isolate and three E. avium isolates were susceptible 
to all tested antibiotics.  
 
 
Table 2. Characteristics of resistance and virulence patterns among BIO+ E. faecalis, BIO+ E. faecium, and other            
BIO+ Enterococcus strains. AMP, ampicillin; IMP, imipenem; CN, gentamicin; S, streptomycin; VA, vancomycin;              
TEI, teicoplanin; esp, enterococcal surface protein; as, aggregation substance; gel, gelatinase; hyl, hyaluronidase,                    
ace, collagen adhesin; c, cytolysin; α, β, types of hemolysis. 
No. of 
inactive 
antibiotics 
Resistance pattern 
No. of 
virulence 
genes 
Virulence pattern 
No. (%) 
of 
strains 
BIO+ E. faecalis (n = 4) 
4 AMP IMP CN S   3  as gel   c α 1 (25) 
1   CN    4 esp as gel   c  2 (50) 
0       5 esp as gel ace  c  1 (25) 
BIO+ E. faecium (n = 18) 
5 
AMP IMP  S VA TEI 
3 
esp   ace hyl  α 2 (11.1) 
AMP IMP CN  VA TEI esp   ace hyl  α 1 (5.5) 
4 
AMP IMP     esp   ace hyl  α 1 (5.5) 
AMP IMP CN S   esp   ace hyl  α 5 (27.8) 
AMP IMP CN S   2 esp   ace   β 2 (11.1) 
3 
AMP IMP  S   
3 
esp   ace hyl  α 5 (27.8) 
AMP IMP CN    esp   ace hyl  α 2 (11.1) 
Unusual BIO+ Enterococcus (n = 8) 
4 
AMP IMP CN  VA  2 esp    hyl  α 1 (12.5) 
AMP IMP CN S   1 esp      β 1 (12.5) 
3 AMP IMP  S   
2 
esp    hyl   1 (12.5) 
1 
   S      ace hyl  β 1 (12.5) 
    VA  0        1 (12.5) 
0 
      1    ace   β 2 (25) 
      0       β 1 (12.5) 
 
 
 In conclusion, we observed that the 
proportion of isolates producing biofilm was the 
highest among E. faecium isolates, at the middle 
level among the unusual Enterococcus spp. group, 
and the lowest in E. faecalis isolates. Interestingly, 
our data demonstrated that unusual biofilm-forming 
Enterococcus strains have lower resistance to 
antibiotics and are characterized by possession of 
lower virulence capabilities than BIO+ E. faecalis 
and BIO+ E. faecium clinical isolates. Moreover,          
E. faecium strains showed the highest resistance and 
virulence levels. It is well known that E. faecium 
isolates resistant to ß-lactams, aminoglycosides, and 
glycopeptides are considered as multidrug resistant 
(MDR) bacteria, and they represent a particular 
threat to immunocompromised patients [9]. The 
problem with these strains becomes even more 
serious when they are also able to produce biofilm, 
and persist in hospital environments for a very long 
time. However, the high percentage of biofilm-
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forming ability among unusual Enterococcus species, 
observed in this study, indicates that these isolates 
could also stay in the medical environment and, 
consequently, slowly acquire resistance and viru-
lence traits. Therefore, the infections caused by 
these strains should not be underestimated, and 
determination of their susceptibility should always 
be performed. The changing epidemiology and 
increasing resistance to antibiotics among Entero-
coccus species stress the need to search in new 
directions for the treatment and new methods for 
preventing the spread of enterococcal nosocomial 
infections. 
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